Picture of PAION AG logo

PA8 — PAION AG News Story

0.000.00%
de flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapValue Trap

Brief: Paion Q1 EBITDA Up At EUR 15 Mln

May 18 (Reuters) - PAION AG  PA8G.DE :
    * PUBLISHES GROUP QUARTERLY STATEMENT FOR THE FIRST QUARTER
OF
2022
    * CASH AND CASH EQUIVALENTS OF EUR 15.9 MILLION AS OF 31
MARCH
2022
    * EXPANSION OF PARTNER NETWORKS THROUGH LICENSING AND
COOPERATION
AGREEMENTS FOR LATIN AMERICA AND EASTERN EUROPE
    * REVENUES OF EUR 21.5 MILLION WERE RECOGNIZED IN Q1 OF 2022
    * RESEARCH AND DEVELOPMENT EXPENSES IN Q1 OF 2022 AMOUNTED
TO EUR
1.1 MILLION (PRIOR-YEAR PERIOD: EUR 1.3 MILLION)
    * EBITDA IN Q1 OF 2022 AMOUNTED TO EUR 15.0 MILLION AND
INCREASED
BY EUR 17.2 MILLION COMPARED TO PRIOR-YEAR PERIOD
    * OUTLOOK 2022: CONFIRMS ITS OUTLOOK FOR CURRENT FISCAL YEAR
    * LICENSEES GENERATED REMIMAZOLAM REVENUES TOTALLING EUR 0.9
MILLION IN Q1 OF 2022, AMOUNTING TO ROYALTIES FOR PAION OF EUR
0.1 MILLION

Source text for Eikon:  ID:nEQrSrdMa 
Further company coverage:  PA8G.DE 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))

Recent news on PAION AG

See all news